Loading...
Loading...
Among the 8 tracked institutional investors we monitor, RCKT (ROCKET PHARMACEUTICALS INC) is held with a combined value of $93.30M across 26,227,461 shares. The largest holder is VANGUARD GROUP INC with a position worth $29.99M (0.00% of their portfolio). VANGUARD GROUP INC opened a new position in the most recent quarter. 5 funds increased their holdings. 2 funds reduced their position.
Total Institutional Value
$93.30M
Total Shares Held
26,227,461
Institutional Holders
8
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | $29.99M | 0.00% | New |
| 2 | BlackRock, Inc. | $28.05M | 0.00% | -0.9% |
| 3 | STATE STREET CORP | $16.06M | 0.00% | +163.8% |
| 4 | MILLENNIUM MANAGEMENT LLC | $11.16M | 0.00% | +74.7% |
| 5 | Point72 Asset Management, L.P. | $3.62M | 0.00% | +99.3% |
| 6 | RENAISSANCE TECHNOLOGIES LLC | $2.28M | 0.00% | +51.3% |
| 7 | FMR LLC | $1.66M | 0.00% | +17.0% |
| 8 | CITADEL ADVISORS LLC | $473.28K | 0.00% | -90.0% |
As of the latest SEC 13F filings, VANGUARD GROUP INC is the largest institutional holder of RCKT with a position worth $29.99M, representing 0.00% of their portfolio. In total, 8 institutional investors hold RCKT with a combined value of $93.30M.
In the most recent quarter, 1 fund opened a new position in RCKT. Additionally, 5 increased their holdings and 2 reduced their positions.
Institutional investors hold $93.30M worth of RCKT stock across 8 positions. The largest institutional holder is VANGUARD GROUP INC with $29.99M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For RCKT, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their RCKT positions.